EventsViruses 2026 – New Horizons in Virology
Published
This submission belongs to the session S2. Antiviral Therapeutics, Vaccines, and Host Defenses of the event Viruses 2026 – New Horizons in Virology
Published date
09 Mar, 2026
Academic Editor
author-avatarEric Freed
Citation
Chia-Chyi Liu, Yi-An Chen, Yu-Sheng Shen, Chih-Yeu Fang, Ting-Ting Chan, Shang-Rung Wu, Jen-Ren Wang, Suh-Chin Wu, Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development, in Proceedings of Viruses 2026 – New Horizons in Virology, Barcelona, 11 March–13 March 2026, MDPI: Basel, Switzerland
Share
Email
FaceBook
Twitter
Linkedin

Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development

Yi-An Chen 1
Yu-Sheng Shen 2
Ting-Ting Chan 3
image
1. Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan.
2. National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan.
3. School of Dentistry & Institute of Oral Medicine, National Cheng Kung University, Tainan, Taiwan.
4. Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
Abstract
Keywords
Coxsackievirus A16 (CVA16)
hand
foot
and mouth disease (HFMD)
DNA-launched infectious clone
inactivated whole virion vaccine
Serum-free HEK293A suspension culture
bivalent vaccine.